Private Equity

Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.



Sign up for a 7-day FREE trial today!



Latest News in Private Equity

  • May 23, 2024

    Skadden-Led Hg Buys Risk Platform Co. AuditBoard For $3B

    Cooley LLP-advised AuditBoard Inc. on Thursday announced that it has agreed to be bought by European software and services business investor Hg Capital, guided by Skadden Arps Slate Meagher & Flom LLP, in a deal valued at over $3 billion.

  • May 23, 2024

    'New' Facts Don't Permit Do-Over, Kraft-Heinz Tells Chancery

    An institutional shareholder of The Kraft-Heinz Co. is not entitled to a "do-over" on an insider trading lawsuit that Delaware's Court of Chancery dismissed in 2021 because the supposed "new evidence" it offers isn't actually new and wouldn't have made any difference in the case, the company said Thursday.

  • May 23, 2024

    Enforcers Want To Know Where Roll-Ups Are Happening

    The Federal Trade Commission and U.S. Department of Justice are asking for help finding industries where serial acquisitions and roll-up strategies are being used, building on a probe of the healthcare sector launched earlier this year.

  • May 23, 2024

    NY Top Court Revives FanDuel Investors Suit

    New York's top appeals court on Thursday revived a suit brought by FanDuel investors who claim they were deprived of profits from a merger, disagreeing with a lower court's interpretation of Scottish law.

  • May 23, 2024

    Merck To Pay $600M For KKR-Backed Life Sciences Biz

    Menlo Park, California-based Gamma Biosciences said Thursday it has agreed to sell its operating company Mirus Bio for $600 million in cash to Merck KGaA, inking the deal under the guidance of Sidley Austin LLP. 

See more Private Equity news

Private Equity

Areas of Coverage

  • TRANSACTIONS
  • Private equity deals valued at $50MM or more
  • Venture capital investments of $25MM or more
  • Mergers and acquisitions
  • Capital investments, including mezzanine and growth capital deals
  • Joint ventures involving private equity firms
  • Hostile takeovers and leveraged buyouts
  • Distressed investment deals
  • AGENCIES
  • U.S. Commodity Futures Trading Commission
  • Federal Trade Commission
  • Financial Industry Regulatory Authority
  • Public Company Accounting Oversight Board
  • U.S. Department of Justice
  • U.S. Department of the Treasury
  • U.S. Securities and Exchange Commission
  • International competition and securities regulators
  • POLICY & REGULATION
  • Dodd-Frank Act
  • Delaware corporate law
  • Antitrust and consumer protection controls
  • Private equity industry lobbying
  • International banking legislation and regulation
  • ENFORCEMENT
  • Merger reviews
  • Second requests
  • Challenges and divestitures
  • Litigation
  • Antitrust suits
  • Shareholder disputes
  • Corporate governance fights
  • Poison pill challenges
  • Hostile takeover disputes
  • Privacy and consumer protection suits
  • Bankruptcy proceedings involving private equity stakeholders
  • PROFILES
  • Personnel moves
  • Profiles of private equity practices

Readership

  • Private equity lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the private equity industry
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!